RecruitingNCT00001823

Evaluation for NCI Surgery Branch Clinical Research Protocols

Sponsor

National Cancer Institute (NCI)

Enrollment

7,000 participants

Start Date

Jul 11, 1999

Study Type

OBSERVATIONAL

Conditions

Melanoma Synovial Cell Cancer

Summary

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol. ...

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Age \>= 18 years.
Patient suspected of having, or with biopsy proven, malignant disease.
Patient is able to understand and willing to sign a written informed consent document.
Patient is being evaluated for treatment on an NCI-SB protocols.

Exclusion Criteria1

Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.